[Community-acquired pneumonia: a budget impact model]
Massimo Giusti1, Francesco Banfi, Francesco Perrone
1Ospedale San Giovanni Bosco, Torino, Italy.
Le Infezioni in Medicina
|October 20, 2010
Summary
Community-acquired pneumonia (CAP) treatment costs in Italy are primarily driven by treatment failures, not antibiotic expenses. Optimizing first-line therapies can significantly reduce overall hospital expenditures for CAP patients.
Area of Science:
- Infectious Diseases
- Health Economics
- Pharmacoeconomics
Context:
- Community-acquired pneumonia (CAP) presents a significant global health burden with high morbidity and mortality.
- Hospitalized CAP patients incur substantial direct medical costs.
- International and FADOI guidelines provide therapeutic recommendations for CAP management.
Purpose:
- To estimate the impact of different antibiotic therapies on hospital direct costs for CAP patients in Italy.
- To compare the cost-effectiveness of levofloxacin monotherapy versus combination therapies.
- To analyze the cost implications of treatment failure in CAP management.
Summary:
- A budget impact model analyzed direct hospital costs associated with CAP treatment, considering drug, staffing, consumable, and inpatient stay expenses.
- The model evaluated two scenarios: intravenous therapy only and switch therapy.
- Levofloxacin monotherapy was compared against combination therapies, including the cost of first-line treatment failures.
Impact:
- Antibiotic costs represent a minor fraction of total direct hospital costs for CAP.
- Treatment failure is the predominant cost driver in hospitalized CAP patients.
- Findings highlight the economic importance of effective first-line CAP treatment strategies.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: